Brevan Howard Capital Management LP Biocryst Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 79,468 shares of BCRX stock, worth $561,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,468
Previous 94,467
15.88%
Holding current value
$561,044
Previous $583,000
3.43%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BCRX
# of Institutions
279Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$141 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$83.8 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$64.1 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$62.5 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.31B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...